These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29439640)

  • 21. [A Pediatric Case of Acquired Hemophilia A: The Usefulness of the Activated Partial Thromboplastin Time (APTT) Cross-Mixing Test for Early Diagnosis].
    Asai H; Shirayama R; Oshida K; Honda Y; Sato T; Sakai M; Kusuhara K
    J UOEH; 2018; 40(4):331-337. PubMed ID: 30568085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitor Index in the Clot Waveform Analysis-Based Mixing Test Differentiates among Hemophilia A without and with Inhibitors, and Lupus Anticoagulant.
    Shimonishi N; Ogiwara K; Oda Y; Kawabe T; Emmi M; Shima M; Nogami K
    Thromb Haemost; 2021 Jun; 121(6):792-799. PubMed ID: 33412612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of lupus anticoagulants in immediate acting inhibitor positivity in congenital haemophilia A patients.
    Patil R; S C; Parihar A; Mohite A; Shetty S
    Thromb Res; 2018 Dec; 172():29-35. PubMed ID: 30359788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on the Clot Waveform Analysis.
    Wada H; Matsumoto T; Ohishi K; Shiraki K; Shimaoka M
    Clin Appl Thromb Hemost; 2020; 26():1076029620912027. PubMed ID: 32862666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94-9027) for haemophilia A.
    Gu JM; Ramsey P; Evans V; Tang L; Apeler H; Leong L; Murphy JE; Laux V; Myles T
    Haemophilia; 2014 Jul; 20(4):593-600. PubMed ID: 24471985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of a Prethrombotic State in Patients with Hepatocellular Carcinoma, Using a Clot Waveform Analysis.
    Fukui S; Wada H; Ikeda K; Kobayashi M; Shimada Y; Nakazawa Y; Mizutani H; Ichikawa Y; Nishiura Y; Moritani I; Yamanaka Y; Inoue H; Shimaoka M; Shimpo H; Shiraki K
    Clin Appl Thromb Hemost; 2024; 30():10760296241246002. PubMed ID: 38591954
    [No Abstract]   [Full Text] [Related]  

  • 27. The Evaluation of APTT Reagents in Reference Plasma, Recombinant FVIII Products; Kovaltry® and Jivi® Using CWA, Including sTF/7FIX Assay.
    Wada H; Shiraki K; Matsumoto T; Ohishi K; Shimpo H; Sakano Y; Nishii H; Shimaoka M
    Clin Appl Thromb Hemost; 2021; 27():1076029620976913. PubMed ID: 33606948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Case of Acquired Hemophilia A: Usefulness of Various Methods for Judging Mixing Test Results for Monitoring the Effect of Immunosuppressive Therapy.
    Moriai R; Yanagihara N; Endoh A; Yamada S; Mochizuki M; Kondo T; Endoh T; Asanuma K; Takahashi S
    Clin Lab; 2018 Apr; 64(4):623-626. PubMed ID: 29739073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of activated partial thromboplastin time waveform analysis for identification of sepsis and overt disseminated intravascular coagulation in patients admitted to a surgical intensive care unit.
    Dempfle CE; Lorenz S; Smolinski M; Wurst M; West S; Houdijk WP; Quintel M; Borggrefe M
    Crit Care Med; 2004 Feb; 32(2):520-4. PubMed ID: 14758173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance and Interpretation of Clot Waveform Analysis.
    Ruberto MF; Marongiu F; Barcellona D
    Methods Mol Biol; 2023; 2663():163-173. PubMed ID: 37204709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New formulas for mixing test to discriminate between lupus anticoagulant and acquired hemophilia A.
    Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N; Suzuki T; Komiyama Y
    Thromb Res; 2016 Jul; 143():53-7. PubMed ID: 27182981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of factor VIII infusions in haemophilia A patients with high responding inhibitors.
    Kasuda S; Tanaka I; Shima M; Matsumoto T; Sakurai Y; Nishiya K; Giles AR; Yoshioka A
    Haemophilia; 2004 Jul; 10(4):341-6. PubMed ID: 15230947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical analysis and laboratory findings in a patient with acquired hemophilia A].
    Xie BS; Wang WQ; Huang Y; Ye LL; Hu LM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):206-8. PubMed ID: 19236780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in the Composition of Activated Partial Thromboplastin Time (APTT) Reagents Affect Clot Waveform Analysis.
    Kato K; Hatayama Y; Shimohiro H; Ichikawa H; Fukuda T
    Yonago Acta Med; 2022 Aug; 65(3):226-230. PubMed ID: 36061578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Systemic lupus erythematosus with acquired hemophilia A: a case report].
    Yang F; Zhou YS; Jia Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1108-1111. PubMed ID: 30562791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of the APTT waveform for the diagnosis of DIC and prediction of the outcome or bleeding risk.
    Suzuki K; Wada H; Matsumoto T; Ikejiri M; Ohishi K; Yamashita Y; Imai H; Iba T; Katayama N
    Thromb J; 2019; 17():12. PubMed ID: 31297038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unusual Initial Manifestation of Acquired Hemophilia A: A Normal Activated Partial Thromboplastin Time, Intramuscular Hematoma and Cerebral Hemorrhage.
    Tsuyama N; Ichiba T; Naito H
    Intern Med; 2016; 55(22):3347-3349. PubMed ID: 27853081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activated partial thromboplastin time reagent sensitivity to the presence of the lupus anticoagulant.
    Adcock DM; Marlar RA
    Arch Pathol Lab Med; 1992 Aug; 116(8):837-40. PubMed ID: 1497465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exogenous Magnesium Chloride Reduces the Activated Partial Thromboplastin Times of Lupus Anticoagulant-Positive Patients.
    Tokutake T; Baba H; Shimada Y; Takeda W; Sato K; Hiroshima Y; Kirihara T; Shimizu I; Nakazawa H; Kobayashi H; Ishida F
    PLoS One; 2016; 11(6):e0157835. PubMed ID: 27355205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating Factor VIII Concentrates Using Clot Waveform Analysis.
    Wada H; Shiraki K; Matsumoto T; Shimpo H; Sakano Y; Nishii H; Tamaki S; Suzuki K; Tawara I; Yamashita Y; Shimaoka M
    J Clin Med; 2024 Jun; 13(13):. PubMed ID: 38999423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.